These plans cover you against ailments and guarantees
complete financial security of you and your family.
Low cost, easy to understand and simple term insurance plan, click2Protect 3D Plus has been designed to ensure comprehensive savings and
complete financial security of the policy holders.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other
security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over
financial reporting; 29) the outcome or impact
of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to
complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include, among others: the unfavorable outcome
of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any
of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components
of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence
of efficacy and adequacy
of bridging to buprenorphine; clinical development activities may not be
completed on time or at all; the results
of our clinical development activities may not be positive, or predictive
of real - world results or
of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's
financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights
of third parties, or have unintended side effects, adverse reactions or incidents
of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S.
Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018
financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or
complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S.
Securities and Exchange Commission (the SEC).
George is currently
completing the
Securities Industry Institute program, sponsored by the
Securities Industry and
Financial Markets Association, at the Wharton School
of Business.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, operating in a highly competitive industry; changes in the retail landscape or the loss
of key retail customers; the Company's ability to maintain, extend and expand its reputation and brand image; the impacts
of the Company's international operations; the Company's ability to leverage its brand value; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment
of the carrying value
of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's ability to realize the anticipated benefits from its cost savings initiatives; changes in relationships with significant customers and suppliers; the execution
of the Company's international expansion strategy; tax law changes or interpretations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; the Company's ability to
complete or realize the benefits from potential and
completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the United States and in various other nations in which we operate; the volatility
of capital markets; increased pension, labor and people - related expenses; volatility in the market value
of all or a portion
of the derivatives we use; exchange rate fluctuations; risks associated with information technology and systems, including service interruptions, misappropriation
of data or breaches
of security; the Company's ability to protect intellectual property rights; impacts
of natural events in the locations in which we or the Company's customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's ownership structure; the impact
of future sales
of its common stock in the public markets; the Company's ability to continue to pay a regular dividend; changes in laws and regulations; restatements
of the Company's consolidated
financial statements; and other factors.
Forward Looking Statements This press release may be deemed to contain forward - looking statements, which are subject to the safe harbor provisions
of the Private
Securities Litigation Reform Act
of 1995, including the expected completion
of the acquisition, the time frame in which this will occur, the expected benefits to Facebook and WhatsApp from
completing the acquisition, and the expected
financial performance
of Facebook following completion
of the acquisition.
This research, which was honoured with the William F. Sharpe Award for Scholarship in
Financial Research, was
completed during a particularly relevant time when the
Securities and Exchange Commission and the Committee
of European
Securities Regulators were evaluating their market information disclosure policies.
Plaintiffs in the court case that threw out the Department
of Labor's fiduciary rule declared «
complete victory» against the rule and said the way is now clear for the
Securities and Exchange Commission to create a new standard that would apply across
financial disciplines.
The only comprehensive retirement training organization in the
financial services industry focused exclusively on educating professionals on the nuances
of Social
Security retirement planning, the organization creates and provides a training course on Social
Security retirement benefits and claiming strategies and provides advisors with the opportunity, for those inclined to do so, to sit for a comprehensive exam that if
completed successfully will provide them with the Certified in Social
Security Claiming Strategies designation.
One
of the consequences
of such devotion is
complete financial security for the clubs.
SXSW 2013 Film Review
complete coverage
of the SXSW Film Festival 2013 Cheap Thrills Director: E.L. Katz, Screenwriters: Trent Haaga, David Chirchirillo Recently fired and facing eviction, the married father
of a newborn has his life turned upside down when he meets a wealthy couple who offer a path to
financial security... but at a price.
Finally, no discussion
of Social
Security would be
complete without an update on the program's
financial condition and what it could mean for current and future retirees.
These materials are not intended to be
complete or to constitute all
of the information necessary to evaluate adequately the consequences
of investing in any
securities or other
financial instruments described herein.
The information, data, analyses and opinions contained herein (1) include the confidential and proprietary information
of Morningstar, (2) may include, or be derived from, account information provided by your
financial advisor which can not be verified by Morningstar, (3) may not be copied or redistributed, (4) do not constitute investment advice offered by Morningstar, (5) are provided solely for information purposes and therefore are not an offer to buy or sell a
security, and (6) are not warranted to be correct,
complete, or accurate.
They offer
complete security of investment combined with attractive returns.These schemes also act as instruments
of financial Continue Reading...
These materials contain information that is subject to change and that is not intended to be
complete or to constitute all
of the information necessary to evaluate adequately the consequences
of investing in any
securities or other
financial instruments described herein.
After
completing a test
of the
financial guarantors on Dec. 19, S&P put the AAA ratings of MBIA, Ambac, Security Capital Assurance Ltd. and CIFG Financial Guaranty on negative
financial guarantors on Dec. 19, S&P put the AAA ratings
of MBIA, Ambac,
Security Capital Assurance Ltd. and CIFG
Financial Guaranty on negative
Financial Guaranty on negative outlook.
Representation
of securities brokerage firms in disputes with
financial advisors, including a
complete defense award against former broker challenging stock forfeiture provisions in an incentive compensation plan.
Future Generali Life Insurance provides a
complete range
of simplified solutions for the
financial security of customers and enterprises, including savings, family protection, unit linked policies, as well as group products.
This plan comes loaded with a host
of benefits and features to ensure comprehensive protection and
complete financial security for the policy holders.
Personal accident plans safeguard you from adversities ensuring
complete financial security and peace
of mind.
This policy will provide the
complete financial security to the family
of the life insured in case
of his untimely death in an accident.
IMG provides
complete plan administration expertise with the help
of globally recognized underwriter, Sirius International Insurance Corporation, who offers the
financial security and reputation demanded by international consumers.
With operations spread across 75 branches and a
complete range
of simplified solutions for the
financial security of customers and enterprises, we aim to become the first choice by delivering relevant and accessible insurance solutions.
Giving your members the
complete reassurance
of a lasting
financial security and peace
of mind.
In this scenario, an ideal option is to go for selection
of an ideal investment plan that provides a
complete financial security and big returns.
With its superlative
financial security and investment management services, Bharti AXA offers a range
of life insurance and wealth management products to ensure
complete financial protection and peace
of mind for all its customers and patrons.
It provides your family with additional
financial security and gives you
complete peace
of mind.
Future Generali Life Insurance Company offers its customers and enterprises a
complete range
of simplified solutions for the
financial security - family protection, ULIPs, savings and group plans as well.
Lump sum death benefit is paid immediately on death
of Life Insured ensuring
complete financial security for your loved ones in your absence
Future Generali Life Insurance Company offers its customers and enterprises a
complete range
of simplified solutions for the
financial security - family protection, ULIPs, Endowment plans, savings and group plans as well.
Future Generali Life Insurance Company offers its customers and enterprises a
complete range
of simplified solutions for the
financial security — family protection, ULIPs, savings and group plans as well.
Financial service groups Credit Suisse and ING have
completed the first successful transfer
of about $ 30 mln in
securities on R3's blockchain platform.
FirstLink is a one - source (retail) banking
security solutions provider delivering a comprehensive line
of products and services ranging from
financial equipment sales to on - site survey analysis and full, life - cycle management service / testing, as well as
complete system maintenance plans for all your banking needs.
Auditor, February 2009 to Present Cityland
Financial Services - New Cityland, CA â $ cents Monitored status
of internal controls and produced reports on efficiency and
security â $ cents Provided risk assessment and management services, provided suggestions to reduce risk â $ cents
Completed audit tests and documented findings in reports to management
IT Project Manager — Professional Highlights Serve multinational corporations in a variety
of technology based strategic planning and administration roles Offer expertise as a consultant, programmer, engineer, business analyst, and database administrator Lead technology projects for NASA, U.S. Customs, American Express, and General Electric Design and implement reporting, customer service, marketing, sales, and
financial management software Responsible for network and database design, administration, and
security Oversee enterprise - wide hardware and software upgrades resulting in increased efficiency Minimize operational and manpower costs through effective technology solutions Serve as forecast budget analyst for Joint Project Management Operations at Kennedy Space Center Develop reporting application tool using crystal reports engine on CD throughout Kennedy Space Center and Cape Canaveral Air Station resulting in $ 500,000 savings on user licensing fees Create detailed project plan with well - defined tasks, milestones, client sign - offs, test cycles, and specifications which served to communicate project progress to management Develop visual basic application for
financial banking Institution using crystal reports to reduce the company's response time resulting in initial reporting from 2 - 3 hours to just 45 seconds Oversee multimillion - dollar software implementation for Miami Air from a consultancy level Upgrade Great Plains software platform and administered
security access for Miami internal databases Write over 200 SQL stored procedures from access databases for
financial institutions Compose business correspondence and prepared statistical spreadsheet analysis for Kennedy Space Center Recognized by colleagues and superiors for outstanding job performance, reliability, and efficiency Conduct surveys
of operations to assess needs and identify high priority improvements
Complete major product releases meeting very aggressive schedules and budgets Serve as a member
of the International Cyber Threat Task Force Utilize fluencies in English, Portuguese, Arabic, French, and German to communicate with a diverse clientele Continually study emerging technologies and industry best practices Perform all duties with positivity, professionalism, and integrity
Professional Duties & Responsibilities Managed all daily operations
of military dining facility serving over 180,000 meals annually Responsible for equipment and facility valued at more than $ 2 million Oversaw food inventory and orders
of approximately $ 720,000 annually Designed and implemented daily menu, 1,500 line items, and 48 ethnic dishes Trained, directed, and reviewed kitchen and service staff Maintained 98 % customer satisfaction rate for both food service and meal quality Collected customer feedback and designed strategies to improve client experience Ensured 100 % compliance with all applicable FDA food safety regulations Performed approximately 200 facility inspections and staff evaluations Programmed and repaired cash registers to guarantee accurate
financial operations Authored and presented meal, service, personnel, and
financial reports for senior leadership Devoted free time to honing skills and assuming additional duties Assisted base with
security operations, logistics, inventory, and other tasks as needed
Completed all assignments in a professional and positive manner Created an atmosphere
of respect and devotion to team goals Received exemplary reviews resulting in consistent promotions ahead
of schedule
I was a senior vice president and the bank I worked for opened up a real estate company, along with an insurance and
securities division, as part
of a
complete financial services program.